OTHR-12. DRIVING RECOMMENDATIONS IN PATIENTS WITH NEWLY DIAGNOSED BREAST CANCER BRAIN METASTASES

por Swartz, Leigh, Egloff, Heidi, Morikawa, Aki, Van Poznak, Catherine
Publicado 2019

Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics

por Nelson, David R., Brown, Jacqueline, Morikawa, Aki, Method, Michael
Publicado 2022

Development of CNS metastases in breast cancer patients treated with curative intent: a case–control study

por Chakrabarti, Katherine, Swartz, Leigh K, Gill, Anoop, Fang, Fang, Kidwell, Kelley M, Morikawa, Aki
Publicado 2020

Allelic imbalances of chromosomes 8p and 18q and their roles in distant relapse of early stage, node-negative breast cancer

por Morikawa, Aki, Williams, Tanisha Y, Dirix, Luc, Colpaert, Cecile, Goodman, Michael, Lyles, Robert H, Zhong, Diansheng, Zhou, Wei
Publicado 2005

MLTI-02. A PHASE I TRIAL OF SORAFENIB WITH WHOLE BRAIN RADIOTHERAPY (WBRT) IN BREAST CANCER PATIENTS WITH BRAIN METASTASES AND A CORRELATIVE FLT-PET BRAIN IMAGING STUDY IN PATIENTS...

por Morikawa, Aki, Grkovski, Milan, Patil, Sujata, Jhaveri, Komal, Tang, Kendrick, Humm, John, Holodny, Andrei, Beal, Kathryn, Schoder, Heiko, Seidman, Andrew
Publicado 2019

OTHR-13. IMPACT the brain: improving metastatic breast cancer patient access to coordinated treatment

por Grogan, Nicole, Pierce-Gjeldum, Donna, Swartz, Leigh, Verbal, Kait, Merajver, Sofia, Friese, Christopher, Kiyota, Ayano, Heth, Jason, Leung, Denise, Smith, Sean, Gabel, Nicolette, Kim, Michelle, Morikawa, Aki
Publicado 2021

LMD-09. Outcomes and symptom benefit from palliative radiotherapy for leptomeningeal disease in breast cancer patients

por Takayesu, Jamie, Sapir, Eli, Xie, Jiaheng, Sun, Yilun, Morikawa, Aki, Junck, Larry, Leung, Denise, Umemura, Yoshie, Heth, Jason, Al-Holou, Wajd, Wahl, Daniel, Lawrence, Theodore, Mayo, Charles, Hayman, James, Kim, Michelle
Publicado 2021

IMPACT the Brain: A Team-Based Approach to Management of Metastatic Breast Cancer With CNS Metastases

por Fleege, Nicole M. Grogan, Pierce-Gjeldum, Donna, Swartz, Leigh K., Verbal, Kait, Merajver, Sofia, Friese, Christopher R., Kiyota, Ayano, Heth, Jason, Leung, Denise, Smith, Sean R., Gabel, Nicolette, Kim, Michelle M., Morikawa, Aki
Publicado 2023

Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer

por Pernas, Sonia, Guerriero, Jennifer L., Naumenko, Sergey, Goel, Shom, Regan, Meredith M., Hu, Jiani, Harrison, Beth T., Lynce, Filipa, Lin, Nancy U., Partridge, Ann, Morikawa, Aki, Hutchinson, John, Mittendorf, Elizabeth A., Sokolov, Artem, Overmoyer, Beth
Publicado 2022

TIPS-19 TRIAL IN PROGRESS: SECONDARY BRAIN METASTASES PREVENTION AFTER ISOLATED INTRACRANIAL PROGRESSION ON TRASTUZUMAB/PERTUZUMAB OR T-DM1 IN PATIENTS WITH ADVANCED HUMAN EPIDERMA...

por Van Swearingen, Amanda, Sammons, Sarah, Noteware, Laura, Bagegni, Nusayba, Moulton, Kelly, Threatt, Stevie, Jaggers, Denise, Shea, Shannon, Lipp, Eric, Riley, Erin, Jung, Sin-Ho, Broadwater, Gloria, Ross, Masey, Strickland, Kimberly, Beyer, Sasha, Conlin, Alison, Morikawa, Aki, Murthy, Rashmi, Anders, Carey
Publicado 2023

TRLS-07. BRAINSTORM: OUTCOMES FROM A MULTI-INSTITUTIONAL PHASE I/II STUDY OF RRx-001 IN COMBINATION WITH WHOLE BRAIN RADIATION THERAPY FOR PATIENTS WITH BRAIN METASTASES

por Kim, Michelle, Parmar, Hemant, Schipper, Matthew, Devasia, Theresa, Aryal, Madhava, Kesari, Santosh, O’Day, Steven, Morikawa, Aki, Spratt, Daniel, Junck, Larry, Mammoser, Aaron, Hayman, James, Lawrence, Theodore, Tsien, Christina, Aiken, Robert, Goyal, Sharad, Abrouk, Nacer, Trimble, Malcolm, Cao, Yue, Lao, Christopher
Publicado 2019

Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment

por Morikawa, Aki, Li, Jinju, Ulintz, Peter, Cheng, Xu, Apfel, Athena, Robinson, Dan, Hopkins, Alex, Kumar-Sinha, Chandan, Wu, Yi-Mi, Serhan, Habib, Verbal, Kait, Thomas, Dafydd, Hayes, Daniel F., Chinnaiyan, Arul M., Baladandayuthapani, Veerabhadran, Heth, Jason, Soellner, Matthew B., Merajver, Sofia D., Merrill, Nathan
Publicado 2023

Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases

por Lazaratos, Anna-Maria, Maritan, Sarah M., Quaiattini, Andrea, Darlix, Amelie, Ratosa, Ivica, Ferraro, Emanuela, Griguolo, Gaia, Guarneri, Valentina, Pellerino, Alessia, Hofer, Silvia, Jacot, William, Stemmler, Hans-Joachim, van den Broek, Marcel P.H., Dobnikar, Nika, Panet, Francois, Lahijanian, Zubin, Morikawa, Aki, Seidman, Andrew D., Soffietti, Riccardo, Panasci, Lawrence, Petrecca, Kevin, Rose, April A.N., Bouganim, Nathaniel, Dankner, Matthew
Publicado 2023

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial

por Haddad, Tufia C., Suman, Vera J., D’Assoro, Antonino B., Carter, Jodi M., Giridhar, Karthik V., McMenomy, Brendan P., Santo, Katelyn, Mayer, Erica L., Karuturi, Meghan S., Morikawa, Aki, Marcom, P. Kelly, Isaacs, Claudine J., Oh, Sun Young, Clark, Amy S., Mayer, Ingrid A., Keyomarsi, Khandan, Hobday, Timothy J., Peethambaram, Prema P., O’Sullivan, Ciara C., Leon-Ferre, Roberto A., Liu, Minetta C., Ingle, James N., Goetz, Matthew P.
Publicado 2023